Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Sales | 10,926,770 | 11,417,440 | 10,645,280 | 10,695,730 | 10,198,250 |
| Cost of Goods | 1,616,540 | 2,745,439 | 2,291,250 | 2,208,840 | 1,987,900 |
| Gross Profit | 5,708,980 | 8,672,607 | 8,287,500 | 8,407,850 | 8,202,280 |
| Operating Expenses | 3,143,230 | 5,566,969 | 4,665,240 | 4,999,510 | 4,516,610 |
| Operating Income | 6,167,540 | 3,105,472 | 3,689,040 | 3,488,221 | 3,694,640 |
| Other Income | -3,360,210 | 207,007 | 102,210 | -22,411 | 109,370 |
| Pre-tax Income | 2,807,330 | 3,312,479 | 3,791,250 | 3,465,810 | 3,804,010 |
| Income Tax | 799,100 | 978,200 | 1,117,500 | 1,023,120 | 1,121,920 |
| Net Income Continuous | 2,995,482 | 2,308,780 | 2,690,580 | 2,460,880 | 2,684,232 |
| Net Income | $2,995,482 | $2,308,780 | $2,690,580 | $2,460,880 | $2,684,232 |
| EPS Basic Total Ops | 1.33 | 0.50 | 1.15 | 1.08 | 1.16 |
| EPS Basic Continuous Ops | 1.33 | 0.50 | 1.15 | 1.07 | 1.16 |
| EPS Diluted Total Ops | 1.33 | 0.50 | 1.15 | 1.06 | 1.16 |
| EPS Diluted Continuous Ops | 1.33 | 0.50 | 1.15 | 1.07 | 1.16 |
| EBITDA(a) | $6,526,479 | $4,302,941 | $3,190,200 | $4,148,491 | $4,101,330 |